GENTEX CORP
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
GNTX$19.42-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
CONSOLIDATED BALANCE SHEETS
AS OF DECEMBER 31, 2025 AND 2024
| 2025 | 2024 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $145,645,715 | $233,318,766 |
| Short-term investments | 5,386,566 | 22,304,829 |
| Accounts receivable, net | 368,517,569 | 295,344,353 |
| Inventories, net | 516,253,617 | 436,497,445 |
| Prepaid expenses and other | 92,631,001 | 49,862,777 |
| Total current assets | 1,128,434,468 | 1,037,328,170 |
| PLANT AND EQUIPMENT: | ||
| Land, buildings and improvements | 591,487,990 | 531,261,137 |
| Machinery and equipment | 1,240,212,788 | 1,065,109,667 |
| Construction-in-process | 83,048,392 | 177,907,293 |
| Total Plant and Equipment | 1,914,749,170 | 1,774,278,097 |
| Less- Accumulated depreciation | (1,123,813,792) | (1,045,796,630) |
| Net Plant and Equipment | 790,935,378 | 728,481,467 |
| OTHER ASSETS: | ||
| Goodwill | 357,211,919 | 340,668,927 |
| Long-term investments | 272,975,939 | 339,604,044 |
| Intangible assets, net | 189,341,387 | 195,157,160 |
| Deferred tax asset | 108,338,592 | 53,154,832 |
| Patents and other assets, net | 81,355,151 | 66,426,375 |
| Total Other Assets | 1,009,222,988 | 995,011,338 |
| TOTAL ASSETS | $2,928,592,834 | $2,760,820,975 |
| LIABILITIES AND SHAREHOLDERS’ INVESTMENT | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $248,983,498 | $168,314,912 |
| Accrued liabilities: | ||
| Salaries, wages and vacation | 23,197,164 | 19,526,367 |
| Income taxes | 846,965 | 439,545 |
| Royalties | 29,358,102 | 21,087,480 |
| Dividends payable | 25,853,403 | 27,264,897 |
| Short-term debt | 3,795,925 | — |
| Other | 55,507,912 | 16,059,475 |
| Total current liabilities | 387,542,969 | 252,692,676 |
| OTHER NON-CURRENT LIABILITIES | 49,209,006 | 36,028,644 |
| DEFERRED INCOME TAXES | 908,922 | — |
| TOTAL LIABILITIES | 437,660,897 | 288,721,320 |
| REDEEMABLE NON-CONTROLLING INTEREST | 3,102,213 | — |
| SHAREHOLDERS’ INVESTMENT: | ||
| Common stock, par value 0.06 per share; 400,000,000 shares authorized; 215,445,024 and 227,207,472 shares issued and outstanding in 2025 and 2024, respectively. | 12,926,701 | 13,632,448 |
| Additional paid-in capital | 1,008,589,267 | 1,010,440,420 |
| Retained earnings | 1,466,046,002 | 1,450,287,128 |
| Accumulated other comprehensive income (loss): | ||
| Unrealized income (loss) on investments, net | 1,347,044 | (591,605) |
| Unrealized loss on derivatives | (768,985) | — |
| Cumulative translation adjustment | (310,305) | (5,817,736) |
| TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT | 2,487,829,724 | 2,467,950,655 |
| Non-controlling Interest | — | 4,149,000 |
| TOTAL SHAREHOLDERS' INVESTMENT | 2,487,829,724 | 2,472,099,655 |
| TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT | $2,928,592,834 | $2,760,820,975 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.